SEI Investments’s Nurix Therapeutics NRIX Stock Holding History

SEI Investments’s Portfolio NRIX Stock Details NRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.61M	Buy	107,510 +25,402	+31%	+$433K	﹤0.01%	1818
2026 Q1	$1.27M	Buy	82,108 +46,132	+128%	+$765K	﹤0.01%	2232
2025 Q4	$682K	Buy	+35,976	New	+$517K	﹤0.01%	2365
2025 Q3	–	Sell	-13,833	Closed	-$158K	–	2881
2025 Q2	$158K	Hold	13,833	–	–	﹤0.01%	2615
2025 Q1	$164K	Buy	+13,833	New	+$231K	﹤0.01%	2504

Other funds holding NRIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SEI Investments's NRIX Position: Q2 2026 in Review

SEI Investments increased its Nurix Therapeutics (NRIX) stake by 31% in Q2 2026, buying an estimated $433K and bringing the position to 107,510 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

SEI Investments first reported a position in NRIX in Q1 2025 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

SEI Investments held 107,510 shares of Nurix Therapeutics worth $2.61M as of Q2 2026.
SEI Investments bought 25,402 Nurix Therapeutics shares in Q2 2026, an estimated $433K.
Nurix Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1818 holding.
SEI Investments first reported a position in Nurix Therapeutics in Q1 2025 and has held it in 5 quarters since.
211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.